Natural Product: NPC580776

Natural Product IDNPC580776
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
(1~{R},3~{a}~{S},5~{a}~{R},5~{b}~{R},8~{R},9~{R},11~{a}~{R})-1-(1-formylvinyl)-9-hydroxy-8-(hydroxymethyl)-5~{a},5~{b},8,11~{a}-tetramethyl-1,2,3,4,5,6,7,7~{a},9,10,11,11~{b},12,13,13~{a},13~{b}-hexadecahydrocyclopenta[a]chrysene-3~{a}-carboxylic acid
IUPAC Name (1~{R},3~{a}~{S},5~{a}~{R},5~{b}~{R},8~{R},9~{R},11~{a}~{R})-1-(1-formylvinyl)-9-hydroxy-8-(hydroxymethyl)-5~{a},5~{b},8,11~{a}-tetramethyl-1,2,3,4,5,6,7,7~{a},9,10,11,11~{b},12,13,13~{a},13~{b}-hexadecahydrocyclopenta[a]chrysene-3~{a}-carboxylic acid
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey QFMLBJPCQONEAF-IQSFLHLTSA-N
Standard InCHI InChI=1S/C30H46O5/c1-18(16-31)19-8-13-30(25(34)35)15-14-28(4)20(24(19)30)6-7-22-26(2)11-10-23(33)27(3,17-32)21(26)9-12-29(22,28)5/h16,19-24,32-33H,1,6-15,17H2,2-5H3,(H,34,35)/t19-,20?,21?,22?,23+,24?,26-,27-,28+,29+,30-/m0/s1
SMILES C=C(C=O)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)C(CCC4[C@@]5(C)CC[C@@H](O)[C@@](C)(CO)C5CC[C@]43C)C12

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   486.33 Volume:   520.695
?
Van der Waals volume.
Dense:   0.934 LogP:   2.619
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.505
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.934
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   4.0 Rigid Bonds:   28.0
TPSA:   94.83
?
Topological Polar Surface Area.
H-Bond Acceptor:   5.0
H-Bond Donor:   3.0 Rings:   5.0
Heavy Atoms:   5.0

MedChem Properties

QED Drug-Likeness Score:   0.373 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   5.056 Fsp3:   0.867
MCE-18:   104.5
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.558 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.003
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.018
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.239 Promiscuous compounds:   0.066

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.329 MDCK Permeability:   -5.026
Pgp-inhibitor:   0.0 Pgp-substrate:   0.01
PAMPA:   1.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.0
20% Bioavailability (F20%):   0.908 30% Bioavailability (F30%):   0.218
50% Bioavailability (F50%):   0.995

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.029 MRP1:   0.864
Plasma Protein Binding (PPB):   77.178% Volume Distribution (VD):   -0.176
Fu: 22.89%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.98
OATP1B3 inhibitor:   0.035 BCRP inhibitor:   0.09
BSEP inhibitor:   0.979

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.002 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.403 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.006 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.134 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.0
HLM stability:   0.0
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  5.915 Half-life (T1/2):  1.338

ADMET: Toxicity

hERG Blockers:  0.038 hERG Blockers (10um):  0.074
Human Hepatotoxicity (H-HT):  0.803 Drug-induced Liver Injury (DILI):  0.128
AMES Toxicity:  0.079 Rat Oral Acute Toxicity:  0.144
Maximum Recommended Daily Dose:  0.53 Skin Sensitization:  0.719
Carcinogencity:  0.875 Eye Corrosion:  0.002
Eye Irritation:  0.331 Respiratory Toxicity:  0.316
Drug-induced Neurotoxicity:  0.006 Ototoxicity:  0.793
Hematotoxicity:  0.033 Drug-induced Nephrotoxicity:  0.283
Genotoxicity:  0.162 RPMI-8226 Immunitoxicity:  0.018
A549 Cytotoxicity:  0.019 Hek293 Cytotoxicity:  0.304
BCF:   0.638
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.902
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.683
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.662
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO40286 Phoradendron vernicosum Species Viscaceae Eukaryota Aerial Parts n.a. n.a. PMID[29120172]
NPO40286 Phoradendron vernicosum Species Viscaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC580776 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC488165
0.8644 High Similarity NPC488164
0.8644 High Similarity NPC264005
0.7302 Intermediate Similarity NPC264317
0.7302 Intermediate Similarity NPC294438
0.7231 Intermediate Similarity NPC16377
0.6866 Remote Similarity NPC269360
0.6471 Remote Similarity NPC151191
0.6324 Remote Similarity NPC201655
0.6269 Remote Similarity NPC30583
0.6176 Remote Similarity NPC213832
0.6143 Remote Similarity NPC601275
0.5972 Remote Similarity NPC169933
0.5942 Remote Similarity NPC24772
0.5942 Remote Similarity NPC488506
0.5942 Remote Similarity NPC220498
0.5909 Remote Similarity NPC68828
0.5882 Remote Similarity NPC192744
0.5857 Remote Similarity NPC195395
0.5797 Remote Similarity NPC80590
0.5775 Remote Similarity NPC2783
0.5714 Remote Similarity NPC476071
0.5652 Remote Similarity NPC119743
0.5634 Remote Similarity NPC271974
0.5634 Remote Similarity NPC277399
0.5634 Remote Similarity NPC247312
0.5556 Remote Similarity NPC18064
0.5556 Remote Similarity NPC4309
0.5541 Remote Similarity NPC608379
0.5507 Remote Similarity NPC472608
0.5493 Remote Similarity NPC211162
0.5493 Remote Similarity NPC183374
0.5493 Remote Similarity NPC291373
0.5441 Remote Similarity NPC246445
0.5405 Remote Similarity NPC160506
0.5405 Remote Similarity NPC486704
0.5333 Remote Similarity NPC600004
0.527 Remote Similarity NPC474719
0.527 Remote Similarity NPC475061
0.527 Remote Similarity NPC488213
0.5224 Remote Similarity NPC78067
0.5224 Remote Similarity NPC278091
0.5217 Remote Similarity NPC269396
0.52 Remote Similarity NPC611139
0.5195 Remote Similarity NPC481311
0.5195 Remote Similarity NPC603461
0.5132 Remote Similarity NPC478841
0.5132 Remote Similarity NPC488166
0.506 Remote Similarity NPC486709

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC580776 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7302 Intermediate Similarity NPD7520 Phase 1
0.5405 Remote Similarity NPD8035 Phase 2

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data